Case study reveals important new details about rare second cancers related to CAR-T therapy." ScienceDaily. ScienceDaily, 12 June 2024. <www.sciencedaily.comGeorgetown University Medical Center. . Case study reveals important new details about rare second cancers related to CAR-T therapy.
CAR T cell therapy has revolutionized the way certain types of cancer are treated, and the longer those CAR T cells live in a patient's body, the more effectively they respond to cancer. Now, ... Researchers have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell therapy from working. Their study ...
Immunotherapies called chimeric antigen receptor T cells use genetically engineered versions of a patient's own immune cells to fight cancer. These treatments have energized cancer care, ... CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia. It modifies a patient's own T-cells by adding a piece of an antibody that recognizes unique ...Unraveling the Physics of Knitting